Severe controlled hemorrhage resuscitation with small volume poloxamer 188 in sedated miniature swine.

[1]  John A. Jones,et al.  Development and resuscitation of a sedated, mature male miniature swine severe hemorrhage model. , 2011, The Journal of trauma.

[2]  G. Lippi,et al.  Disseminated intravascular coagulation in trauma injuries. , 2010, Seminars in thrombosis and hemostasis.

[3]  R. Hunter,et al.  POLOXAMER 188 PROLONGS SURVIVAL OF HYPOTENSIVE RESUSCITATION AND DECREASES VITAL TISSUE INJURY AFTER FULL RESUSCITATION , 2009, Shock.

[4]  K. North,et al.  Myocardial membrane injury in pediatric cardiac surgery: An animal model. , 2009, The Journal of thoracic and cardiovascular surgery.

[5]  M. Fink,et al.  DRAG-REDUCING HYALURONIC ACID INCREASES SURVIVAL IN PROFOUNDLY HEMORRHAGED RATS , 2009, Shock.

[6]  D. Skarda,et al.  Eight hours of hypotensive versus normotensive resuscitation in a porcine model of controlled hemorrhagic shock. , 2008, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[7]  J. Faulkner,et al.  Poloxamer 188 reduces the contraction-induced force decline in lumbrical muscles from mdx mice. , 2008, American journal of physiology. Cell physiology.

[8]  T. Haas,et al.  Less Impairment of Hemostasis and Reduced Blood Loss in Pigs After Resuscitation from Hemorrhagic Shock Using the Small-Volume Concept with Hypertonic Saline/Hydroxyethyl Starch as Compared to Administration of 4% Gelatin or 6% Hydroxyethyl Starch Solution , 2008, Anesthesia and analgesia.

[9]  J. Metzger,et al.  Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach , 2007, Expert review of cardiovascular therapy.

[10]  S. Day,et al.  Dystrophic heart failure blocked by membrane sealant poloxamer , 2005, Nature.

[11]  J. Differding,et al.  Hypercoagulability is most prevalent early after injury and in female patients. , 2005, The Journal of trauma.

[12]  J. Holcomb.  Fluid resuscitation in modern combat casualty care: lessons learned from Somalia. , 2003, The Journal of trauma.

[13]  R. Emanuele,et al.  Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans. , 2002, Journal of pharmaceutical sciences.

[14]  V. Baum.  Purified Poloxamer 188 for Treatment of Acute Vaso-Occlusive Crisis of Sickle Cell Disease: A Randomized Controlled Trial , 2002 .

[15]  M L Yarmush,et al.  Poloxamer-188 improves capillary blood flow and tissue viability in a cutaneous burn wound. , 2001, The Journal of surgical research.

[16]  E R Schmid,et al.  Monitoring level of sedation with bispectral EEG analysis: comparison between hypothermic and normothermic cardiopulmonary bypass. , 2001, British journal of anaesthesia.

[17]  R. Emanuele.  FLOCOR: a new anti-adhesive, rheologic agent. , 1998, Expert opinion on investigational drugs.

[18]  Z. Ba,et al.  Effects of nonanticoagulant heparin on cardiovascular and hepatocellular function after hemorrhagic shock. , 1996, The American journal of physiology.

[19]  R. Hunter,et al.  Effects of poloxamer 188 in a rabbit model of hemorrhagic shock. , 1994, Annals of clinical and laboratory science.

[20]  S. Stern,et al.  Effect of blood pressure on hemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury. , 1993, Annals of emergency medicine.

[21]  R. Litwak,et al.  Poloxamer 188 improves neurologic outcome after hypothermic circulatory arrest. , 1992, The Journal of thoracic and cardiovascular surgery.

[22]  R. Hunter,et al.  Reduction of myocardial infarct size by poloxamer 188 and mannitol in a canine model. , 1991, American heart journal.

[23]  C. Wade,et al.  Oxygen delivery and demand in conscious pigs subjected to fixed-volume hemorrhage and resuscitated with 7.5% NaCl in 6% Dextran. , 1989, Circulatory shock.

[24]  F. Grover,et al.  The effect of pluronic F-68 on circulatory dynamics and renal and carotid artery flow during hemorrhagic shock. , 1974, The Journal of surgical research.

[25]  A. Hymes,et al.  The influence of an industrial surfactant Pluronic F-68, in the treatment of hemorrhagic shock. , 1971, The Journal of surgical research.

[26]  B. Griffith,et al.  I.V. infusion of a drag-reducing polymer extracted from aloe vera prolonged survival time in a rat model of acute myocardial ischaemia. , 2007, British journal of anaesthesia.

[27]  J. Differding,et al.  A single bolus of 3% hypertonic saline with 6% dextran provides optimal initial resuscitation after uncontrolled hemorrhagic shock. , 2006, The Journal of trauma.

[28]  W. Reinhart,et al.  The non-ionic surfactant Poloxamer 188 (RheothRx) increases plasma and whole blood viscosity. , 1998, Clinical hemorheology and microcirculation.

[29]  C. Mannhalter,et al.  The Prevalence of Moderate and Severe FXII (Hageman Factor) Deficiency among the Normal Population: Evaluation of the Incidence of FXII Deficiency among 300 Healthy Blood Donors , 1994, Thrombosis and Haemostasis.